Impact of Glucagon-like peptide 1 receptor agonists on peripheral arterial disease in people with diabetes mellitus: A narrative review
- 30 December 2022
- journal article
- review article
- Published by Elsevier in Journal of Diabetes and its Complications
- Vol. 37 (2) , 108390
Abstract
No abstract availableKeywords
This publication has 49 references indexed in Scilit:
- Safety and efficacy of once‐weekly dulaglutide versus sitagliptin after 2 years in metformin‐treated patients with type 2 diabetes ( AWARD ‐5): a randomized, phase III studyDiabetes, Obesity and Metabolism, 2015
- Epidemiology of Peripheral Artery DiseaseCirculation Research, 2015
- Is diabetes a hypercoagulable state? A critical appraisalActa Diabetologica, 2015
- Peripheral arterial disease in diabetes—a reviewDiabetic Medicine, 2010
- Peripheral Arterial Disease in Patients With DiabetesJACC, 2006
- Prevalence of and Risk Factors for Peripheral Arterial Disease in the United StatesCirculation, 2004
- Similar Elimination Rates of Glucagon-Like Peptide-1 in Obese Type 2 Diabetic Patients and Healthy SubjectsThe Journal of Clinical Endocrinology & Metabolism, 2003
- Diabetes and AtherosclerosisJAMA, 2002
- Diabetes Mellitus Enhances Vascular Matrix Metalloproteinase ActivityCirculation Research, 2001
- Effect of Diagnostic Criteria on the Prevalence of Peripheral Arterial DiseaseCirculation, 1995